Thu, August 12, 2021
Wed, August 11, 2021
Tue, August 10, 2021
Mon, August 9, 2021
Fri, August 6, 2021
Thu, August 5, 2021

Charles Ryhee Maintained (TDOC) at Buy with Decreased Target to $188 on, Aug 9th, 2021


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. ith-decreased-target-to-188-on-aug-9th-2021.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Charles Ryhee of Cowen & Co., Maintained "Teladoc Health, Inc." (TDOC) at Buy with Decreased Target from $240 to $188 on, Aug 9th, 2021.

Charles has made no other calls on TDOC in the last 4 months.



There are 10 other peers that have a rating on TDOC. Out of the 10 peers that are also analyzing TDOC, 3 agree with Charles's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • David Toung of "Argus Research" Downgraded from Strong Buy to Hold on, Monday, August 2nd, 2021
  • George Hill of "Deutsche Bank" Downgraded from Strong Buy to Hold and Decreased Target to $153 on, Wednesday, July 28th, 2021
  • Matthew Gillmor of "Baird" Initiated at Hold and Held Target at $162 on, Friday, May 28th, 2021


These are the ratings of the 7 analyists that currently disagree with Charles


  • Donald Hooker of "Keybanc" Maintained at Buy with Decreased Target to $180 on, Wednesday, July 28th, 2021
  • Michael Wiederhorn of "Oppenheimer" Maintained at Buy with Decreased Target to $220 on, Wednesday, July 28th, 2021
  • Ryan MacDonald of "Needham" Maintained at Strong Buy with Decreased Target to $205 on, Wednesday, July 28th, 2021
  • Stephanie Davis of "SVB Leerink" Maintained at Buy with Decreased Target to $218 on, Wednesday, July 28th, 2021
  • Jailendra Singh of "Credit Suisse" Maintained at Buy with Decreased Target to $264 on, Friday, April 30th, 2021
  • David Larsen of "BTIG" Maintained at Strong Buy with Decreased Target to $300 on, Thursday, April 29th, 2021
  • Richard Close of "Canaccord Genuity" Maintained at Strong Buy with Decreased Target to $295 on, Thursday, April 29th, 2021

Publication Contributing Sources